The results of the Transwell invasion assay indicated that HT1376 and HT1197 BC cells overexpressing TFCP2L1 had a significantly higher invasive potential than control cells and that ID2 overexpression suppressed the increase in their invasive capacity (Fig. 3f, g). This evidence concerns the gene TFCP2L1 and breast cancer.